Skip to main content
Log in

Increased bone metabolism in a patient undergoing long-term rhG-CSF treatment for idiopathic acquired neutropenia

  • Case Report
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Summary

Recombinant human granulocyte colony-stimulating factor (rhG-CSF) has been used mainly for treatment of chemotherapy-induced neutropenia. The reported side effects were of minor importance. We describe a case of long-term treatment with rhG-CSF, in which we observed enhanced bone remodeling.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bonilla MA et al. (1989) Effects to recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med 320: 1574–1580

    Google Scholar 

  2. Crawford J, Ozer H, Johnson D, et al. (1990) Granulocyte colony-stimulating factor: prevention of chemotherapy-induced febrile neutropenia (FN) in patients with small cell lung cancer (SCLC). A randomized double-blind placebo-controlled trial. Proc Am Soc Clin Oncol 9: 229

    Google Scholar 

  3. Demetri GD, Griffin JD (1991) Granulocyte colony-stimulating factor and its receptor. Blood 77: 2791–2808

    Google Scholar 

  4. Hammond WP et al. (1989) Treatment of cyclic neutropenia with granulocyte colony-stimulating factor. N Engl J Med 320: 1306–1311

    Google Scholar 

  5. Lee MY, Fukanaga R, Lee TJ, Lottsfeldt JL, Nagata S (1991) Bone modulation in sustained hematopoietic stimulation in mice. Blood 77: 2135–2141

    Google Scholar 

  6. Merz WA, Schenk RK (1970) Quantitative structural analysis of cancellous bone. Acta Anat 75: 54–66

    Google Scholar 

  7. Merz WA, Schenk RK (1970) A quantitative histological study on bone formation of human cancellous bone. Acta Anat 76: 1–15

    Google Scholar 

  8. Morstyn G, Campbell L, Souza LM, Alton NK, Keech J, Green M, Sheridan W, Metcalf D, Fox R (1988) Effect of granulocyte colony-stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet 1: 667–672

    Google Scholar 

  9. Pootrakul P, Hungsprenges S, Fucharoen S, et al. (1981) Relation between erythropoiesis and bone metabolism in thalassemia. N Engl J Med 304: 1470–1473

    Google Scholar 

  10. Weite K et al. (1990) Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia. Blood 75: 1056–1063

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Woermann, U.J., Schenk, R., Zimmermann, A. et al. Increased bone metabolism in a patient undergoing long-term rhG-CSF treatment for idiopathic acquired neutropenia. Ann Hematol 66, 267–268 (1993). https://doi.org/10.1007/BF01738479

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01738479

Key words

Navigation